trending Market Intelligence /marketintelligence/en/news-insights/trending/JNVqTHXTQn3j5pWqC4AagQ2 content esgSubNav
In This List

Vanc Pharmaceuticals appoints board member

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise


Vanc Pharmaceuticals appoints board member

Vanc Pharmaceuticals Inc. appointed Robert Sindelar to its board of directors.

The Vancouver, British Columbia-based generic and over-the-counter medicine manufacturer said Sindelar serves as professor, faculty of pharmaceutical sciences at the University of British Columbia.

"Sindelar's background is ideally suited to helping VANC build upon the increasing importance of community pharmacy in healthcare," CEO Bob Rai said in a statement.

Sindelar added: "Current trends suggest that community pharmacy's direct role in patient care services and wellness are growing and VANC has focused on delivering proven enabling technologies to further support this trend and the attendant growth in community pharmacy business activities."